Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
USA is the largest supplier of CTCs Products, with a revenue market share nearly 47.41% in 2017. Europe is the second largest supplier of CTCs products, enjoying revenue market share nearly 26.24% in 2017. Asia has the highest growth rate. Vendors recognize the importance of this region, particularly in China, India and are working towards penetrating this market by strengthening their sales and distribution networks.
In 2018, the global Circulating Tumor Cells market size was 730 million US$ and it is expected to reach 3230 million US$ by the end of 2025, with a CAGR of 20.4% during 2019-2025.
This report focuses on the global Circulating Tumor Cells status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Circulating Tumor Cells development in United States, Europe and China.
The key players covered in this study
Advanced Cell Diagnostics
Greiner Bio-one GmbH
Hangzhou Watson Biotech
Guangzhou Wondfo Biotech
Market segment by Type, the product can be split into
Market segment by Application, split into
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global Circulating Tumor Cells status, future forecast, growth opportunity, key market and key players.
To present the Circulating Tumor Cells development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Circulating Tumor Cells are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.